Identification of Late‐Stage Glycosylation Steps in the Biosynthetic Pathway of the Anthracycline Nogalamycin
Authors:
- 25 November 2011
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 13 (1) , 120-128
Abstract
Nogalamycin is an anthracycline antibiotic that has been shown to exhibit significant cytotoxicity. Its biological activity requires two deoxysugar moieties: nogalose and nogalamine, which are attached at C7 and C1, respectively, of the aromatic polyketide aglycone. Curiously, the aminosugar nogalamine is also connected through a CC bond between C2 and C5′′. Despite extensive molecular genetic characterization of early biosynthetic steps, nogalamycin glycosylation has not been investigated in detail. Here we show that expression of the majority of the gene cluster in Streptomyces albus led to accumulation of three new anthracyclines, which unexpectedly included nogalamycin derivatives in which nogalamine was replaced either by rhodosamine with the CC bond intact (nogalamycin R) or by 2‐deoxyfucose without the CC bond (nogalamycin F). In addition, a monoglycosylated intermediate—3′,4′‐demethoxynogalose‐1‐hydroxynogalamycinone—was isolated. Importantly, when the remaining biosynthetic genes were introduced into the heterologous host by using a two‐plasmid system, nogalamycin could be isolated from the cultures, thus indicating that the whole gene cluster had been identified. We further show that one of the three glycosyltransferases (GTs) residing in the cluster—snogZ—appears to be redundant, whereas gene inactivation experiments revealed that snogE and snogD act as nogalose and nogalamine transferases, respectively. The substrate specificity of the nogalamine transferase SnogD was demonstrated in vitro: the enzyme was able to remove 2deoxyfucose from nogalamycin F. All of the new compounds were found to inhibit human topoisomerase I in activity measurements, whereas only nogalamycin R showed minor activity against topoisomerase II.Keywords
This publication has 34 references indexed in Scilit:
- Expression, purification and crystallization of the cofactor-independent monooxygenase SnoaB from the nogalamycin biosynthetic pathwayActa Crystallographica Section F Structural Biology and Crystallization Communications, 2009
- Characterization of the Alnumycin Gene Cluster Reveals Unusual Gene Products for Pyran Ring Formation and Dioxan BiosynthesisChemistry & Biology, 2008
- The in Vitro Characterization of the Iterative Avermectin Glycosyltransferase AveBI Reveals Reaction Reversibility and Sugar Nucleotide FlexibilityJournal of the American Chemical Society, 2006
- Exploiting the Reversibility of Natural Product Glycosyltransferase-Catalyzed ReactionsScience, 2006
- Crystal Structures of SnoaL2 and AclR: Two Putative Hydroxylases in the Biosynthesis of Aromatic Polyketide AntibioticsJournal of Molecular Biology, 2006
- The entire nogalamycin biosynthetic gene cluster of Streptomyces nogalater: characterization of a 20-kb DNA region and generation of hybrid structuresMolecular Genetics and Genomics, 2001
- Differential Poisoning of Topoisomerases by Menogaril and Nogalamycin Dictated by the Minor Groove-Binding Nogalose SugarBiochemistry, 1997
- Isolation and characterization of aclacinomycin A-non-producing Streptomyces galilaeus (ATCC 31615) mutantsMicrobiology, 1994
- A new shuttle cosmid vector, pKC505, for streptomycetes: its use in the cloning of three different spiramycin-resistance genes from a Streptomyces ambofacienslibraryGene, 1987
- Construction and characterisation of a series of multi-copy promoter-probe plasmid vectors for Streptomyces using the aminoglycoside phosphotransferase gene from Tn5 as indicatorMolecular Genetics and Genomics, 1986